Vita Life Sciences Limited (ASX:VLS – Get Free Report) insider Henry Townsing sold 100,000 shares of the firm’s stock in a transaction dated Friday, April 12th. The stock was sold at an average price of A$2.10 ($1.35), for a total value of A$210,000.00 ($135,483.87).
Henry Townsing also recently made the following trade(s):
- On Wednesday, March 27th, Henry Townsing 300,000 shares of Vita Life Sciences stock.
Vita Life Sciences Stock Performance
The company has a quick ratio of 1.57, a current ratio of 2.98 and a debt-to-equity ratio of 0.89.
Vita Life Sciences Increases Dividend
About Vita Life Sciences
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidant; and bones and joints.
Read More
- Five stocks we like better than Vita Life Sciences
- 3 Best Fintech Stocks for a Portfolio Boost
- Comprehensive PepsiCo Stock Analysis
- How to buy stock: A step-by-step guide for beginnersĀ
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Bear Market Funds to Watch This Year
Receive News & Ratings for Vita Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vita Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.